Etonogestrel/etinilestradiol Actavis 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

etonogestrel/etinilestradiol actavis 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem

etinilestradiol; etinilestradiol - vaginalni dostavni sistem - etinilestradiol 0,015 mg / 24 ura  etinilestradiol0,015 mg / 24 ura; etinilestradiol 0,015 mg / 24 ura - vaginalni obroček s progestogenom in estrogenom

Ryeqo ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

ryeqo

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - hipofize in hipotalamični hormoni in analogi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.